![Mari Nowell MSc, PhD](https://profiles-cardiff.imgix.net/attachments/6840?w=200&h=200&auto=format&crop=faces&fit=crop&q=90")
Dr Mari Nowell
(hi/ei)
MSc, PhD
Timau a rolau for Mari Nowell
Rheolwr Datblygu Ymchwil
STRATEGAETH YMCHWIL A GWEITHREDIADAU
Trosolwg
Rwy'n Rheolwr Datblygu Ymchwil yn y Gwasanaeth Ymchwil, sy'n wynebu'r Coleg Gwyddorau Ffisegol a Pheirianneg ym Mhrifysgol Caerdydd.
Mae gen i brofiad eang o weithio ym maes ymchwil, o ôl-ddoethurol, i gymrawd ymchwil annibynnol ac wedi'i ariannu'n allanol, i Reolwr Datblygu Ymchwil y Coleg.
Rwy'n cefnogi pobl sy'n datblygu eu syniadau ar gyfer cynigion grant ymchwil a ariennir yn allanol ac rwy'n arwain ar alwadau grant ymchwil gyda therfyn sefydliadol a hefyd cyllid EPSRC.
Yn fy rôl flaenorol fel Dirprwy Reolwr Busnes ar gyfer y PVC-RIE, roeddwn yn ymwneud â sefydlu gweithgorau'r Brifysgol o amgylch diwylliant Ymchwil, gan gynnwys gweithgor DORA (Datganiad Asesu Ymchwil) a'r gweithgor Diwylliant Ymchwil, a helpodd i ddrafftio'r cynllun gweithredu Diwylliant Ymchwil cychwynnol.
Rwy'n angerddol am hyrwyddo Cydraddoldeb, Amrywiaeth a Chynhwysiant mewn arferion ymchwil.
Cyhoeddiad
2014
- Gilbert, S. J. et al. 2014. Deletion of P58IPK, the cellular inhibitor of the protein kinases PKR and PERK, causes bone changes and joint degeneration in mice. Frontiers in Endocrinology 5 174. (10.3389/fendo.2014.00174)
- Greenhill, C. J. et al., 2014. Interleukin-10 regulates the inflammasome-driven augmentation of inflammatory arthritis and joint destruction. Arthritis Research and Therapy 16 (4) 419. (10.1186/s13075-014-0419-y)
- Garbers, C. et al., 2014. The interleukin-6 receptor Asp358Ala single nucleotide polymorphism rs2228145 confers increased proteolytic conversion rates by ADAM proteases. Biochimica et Biophysica Acta - Molecular Basis of Disease 1842 (9), pp.1485-1494. (10.1016/j.bbadis.2014.05.018)
2013
- Greenhill, C. J. et al. 2013. Interleukin 10 control of the inflammasome restricts arthritic bone erosion [Abstract]. Cytokine 63 (3), pp.267. (10.1016/j.cyto.2013.06.105)
- Chakraborty, M. et al. 2013. Role of interleukin-6, its receptor and soluble gp130 in chronic lung disease of prematurity. Neonatology 104 (3), pp.161-167. (10.1159/000351015)
- Hayes, A. J. et al. 2013. Spinal deformity in aged zebrafish Is accompanied by degenerative changes to their vertebrae that resemble osteoarthritis. PLoS ONE 8 (9), pp.e75787. (10.1371/journal.pone.0075787)
- Jones, G. W. et al. 2013. Exacerbated inflammatory arthritis in response to hyperactive gp130 signalling is independent of IL-17A. Annals of the Rheumatic Diseases 72 (10), pp.1738-1742. (10.1136/annrheumdis-2013-203771)
- Moideen, A. N. et al. 2013. Characterization of enzymes involved in nicotinamide adenine dinucleotide biosynthesis in rheumatoid arthritis synovium and cytokine-stimulated synovial fibroblasts [Abstracts]. Rhuematology 52 (s1), pp.138-139.
2012
- Bonnet, C. et al. 2012. Intra-articular AMPA/kainate glutamate receptor antagonists alleviate inflammation, pain and pathology in rat antigen induced arthritis [Abstract]. Osteoporosis International 23 , pp.S527-S527.
- Greenhill, C. et al. 2012. The regulation of arthritic bone erosions by il-10 [Abstract]. Rhuematology 51 , pp.48-48. (10.1093/rheumatology/kes117)
- Greenhill, C. J. et al. 2012. Cross-talk between IL-10 and the inflammasome regulates bone erosions during rheumatoid arthritis [Abstract]. Immunology 137 , pp.43-44.
- Jones, G. W. et al. 2012. Interleukin-27 receptor-deficient mice develop exacerbated inflammatory arthritis associated with heightened T- and B-cell responses [Abstract]. Rhuematology 51 (s3), pp.43-44. (10.1093/rheumatology/kes117)
- Moideen, A. N. et al. 2012. Nicotinamide adenine dinucleotide (NAD plus) biosynthesis enzymes in rheumatoid arthritis [Abstract]. Rhuematology 51 (s3), pp.142-142. (10.1093/rheumatology/kes108)
- Nowell, M. A. , Evans, L. C. and Williams, A. S. 2012. PBEF/NAMPT/visfatin: a promising drug target for treating rheumatoid arthritis?. Future Medicinal Chemistry 4 (6), pp.751-769. (10.4155/fmc.12.34)
2011
- Bonnet, C. S. et al., 2011. Intra-articular AMPA/kainate glutamate receptor antagonists alleviate inflammation, pain and pathology in rat antigen induced arthritis [Abstract]. International Journal of Experimental Pathology 92 (6), pp.A14-A14. (10.1111/j.1365-2613.2011.00780.x)
- Evans, L. C. et al. 2011. Suppression of leukocyte infiltration and cartilage degradation by selective inhibition of pre-B cell colony-enhancing factor/visfatin/nicotinamide phosphoribosyltransferase: Apo866-mediated therapy in human fibroblasts and murine collagen-induced arthritis. Arthritis and Rheumatism 63 (7), pp.1866-1877. (10.1002/art.30338)
- Greenhill, C. J. et al. 2011. The regulation of arthritic bone erosions by IL-10 [Abstract]. Immunology 135 (s1), pp.158-158. (10.1111/j.1365-2567.2011.03534.x)
- Jones, G. W. et al. 2011. Interleukin-27 receptor-deficient mice develop exacerbated inflammatory arthritis associated with heightened T- and B-cell responses [Abstract]. Immunology 135 (S1), pp.158. (10.1111/j.1365-2567.2011.03534.x)
- Jones, G. W. et al. 2011. Interleukin-27 receptor-deficient mice develop exacerbated inflammatory arthritis associated with heightened T- and B- cell responses [Abstract]. Arthritis and Rheumatism 63 (s10), pp.S978-S978. (10.1002/art.33310)
2010
- Leggate, M. et al., 2010. The response of interleukin-6 and soluble interleukin-6 receptor isoforms following intermittent high intensity and continuous moderate intensity cycling. Cell Stress and Chaperones 15 (6), pp.827-833. (10.1007/s12192-010-0192-z)
2009
- Nowell, M. A. et al. 2009. Therapeutic targeting of IL-6 trans signaling counteracts STAT3 control of experimental inflammatory arthritis. Journal of Immunology 182 (1), pp.613-622.
2008
- Longhi, M. P. et al., 2008. Interleukin-6 is crucial for recall of influenza-specific memory cd4+ t cells. PLoS Pathogens 4 (2) e1000006. (10.1371/journal.ppat.1000006)
- Jones, S. A. et al. 2008. Appreciating the balance between classical interleukin (IL)-6 receptor signaling and IL-6 trans-signaling: implications for arthritis progression. Immunology Endocrine & Metabolic Agents in Medicinal Chemistry 8 (3), pp.235-246.
- Caterson, B. et al. 2008. Chondroitin sulphate motifs as biomarkers for the stem/progenitor cell niche in musculoskeletal tissues. European Cells and Materials 16 (Supp 2), pp.47-47.
- Hayes, A. J. et al. 2008. Chondroitin sulfate sulfation motifs as putative biomarkers for isolation of articular cartilage progenitor cells. Journal of Histochemistry & Cytochemistry 56 (2), pp.125-38. (10.1369/jhc.7A7320.2007)
- Jones, G. W. et al. 2008. TL1A negatively regulates development of T helper 17 cells [Abstract]. Rheumatology 47 (S2), pp.II20-II20. (10.1093/rheumatology/kem509)
- Nowell, M. A. and Williams, A. S. 2008. Selective inhibition of PBEF activity with a small molecule inhibitor, APO866 ameliorates collagen-induced arthritis [Abstract]. Rheumatology 47 , pp.II58-II59.
2007
- Williams, A. S. et al. 2007. Interferon-γ protects against the development of structural damage in experimental arthritis by regulating polymorphonuclear neutrophil influx into diseased joints. Arthritis & Rheumatism 56 (7), pp.2244-2254. (10.1002/art.22732)
- Campinho, M. A. et al., 2007. Troponin T isoform expression is modulated during Atlantic Halibut metamorphosis. BMC Developmental Biology 7 (1) 71. (10.1186/1471-213X-7-71)
- Carty, S. M. et al. 2007. Combination therapy with etanercept and sgp130 for rheumatoid arthritis is more effective than monotherapy [Abstract]. Rheumatology 46 (s1), pp.I18-I18. (10.1093/rheumatology/kem1007)
2006
- Dimitrov, S. et al., 2006. Sleep enhances IL-6 trans-signaling in humans. The FASEB Journal 20 (12), pp.2174-2176. (10.1096/fj.06-5754fje)
- Nowell, M. A. et al. 2006. Regulation of pre-B cell colony-enhancing factor by STAT-3-dependent interleukin-6 trans-signaling: implications in the pathogenesis of rheumatoid arthritis. Arthritis & Rheumatism 54 (7), pp.2084-2095. (10.1002/art.21942)
- Peake, N. J. et al., 2006. Interleukin-6 signalling in juvenile idiopathic arthritis is limited by proteolytically cleaved soluble interleukin-6 receptor. Rheumatology 45 (12), pp.1485-1489. (10.1093/rheumatology/kel154)
- Richards, P. J. et al., 2006. Functional characterization of a soluble gp130 isoform and its therapeutic capacity in an experimental model of inflammatory arthritis. Arthritis & Rheumatism 54 (5), pp.1662-1672. (10.1002/art.21818)
- Carty, S. M. et al. 2006. TINFa and IL-6/slL-6R interactions regulate the magnitude and the phenotype of synovial Leucocyte infiltration in rheumatoid arthritis [Abstract]. Arthritis and Rheumatism 54 (9), pp.S597-S597.
2005
- Carty, S. M. et al., 2005. Interleukin 6 (IL-6) signalling in rheumatoid arthritis. Rheumatology 44 , pp.I38-I38.
2004
- McLoughlin, R. M. et al. 2004. Differential regulation of neutrophil-activating chemokines by IL-6 and its soluble receptor isoforms. The Journal of Immunology 172 , pp.5676-83.
2003
- Nowell, M. A. et al. 2003. Soluble IL-6 receptor governs IL-6 activity in experimental arthritis: blockade of arthritis severity by soluble glycoprotein 130. The Journal of Immunology 171 (6), pp.3202-3209.
2001
- Coffey, M. J. et al. 2001. Catalytic consumption of nitric oxide by 12/15- lipoxygenase: inhibition of monocyte soluble guanylate cyclase activation. Proceedings of the National Academy of Sciences of the United States of America (PNAS) ISSN 1091-6490 98 (14), pp.8006-8011. (10.1073/pnas.141136098)
- Power, D. M. et al., 2001. Thyroid hormones in growth and development of fish. Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology 130 (4), pp.447-459. (10.1016/S1532-0456(01)00271-X)
2000
- Nowell, M. A. et al. 2000. Cloning and expression of an elongation factor-1a in sea bream (Sparus aurata) larvae and adult tissue. Marine Biotechnology 2 (2), pp.173-179. (10.1007/s101269900022)
Erthyglau
- Gilbert, S. J. et al. 2014. Deletion of P58IPK, the cellular inhibitor of the protein kinases PKR and PERK, causes bone changes and joint degeneration in mice. Frontiers in Endocrinology 5 174. (10.3389/fendo.2014.00174)
- Greenhill, C. J. et al., 2014. Interleukin-10 regulates the inflammasome-driven augmentation of inflammatory arthritis and joint destruction. Arthritis Research and Therapy 16 (4) 419. (10.1186/s13075-014-0419-y)
- Garbers, C. et al., 2014. The interleukin-6 receptor Asp358Ala single nucleotide polymorphism rs2228145 confers increased proteolytic conversion rates by ADAM proteases. Biochimica et Biophysica Acta - Molecular Basis of Disease 1842 (9), pp.1485-1494. (10.1016/j.bbadis.2014.05.018)
- Greenhill, C. J. et al. 2013. Interleukin 10 control of the inflammasome restricts arthritic bone erosion [Abstract]. Cytokine 63 (3), pp.267. (10.1016/j.cyto.2013.06.105)
- Chakraborty, M. et al. 2013. Role of interleukin-6, its receptor and soluble gp130 in chronic lung disease of prematurity. Neonatology 104 (3), pp.161-167. (10.1159/000351015)
- Hayes, A. J. et al. 2013. Spinal deformity in aged zebrafish Is accompanied by degenerative changes to their vertebrae that resemble osteoarthritis. PLoS ONE 8 (9), pp.e75787. (10.1371/journal.pone.0075787)
- Jones, G. W. et al. 2013. Exacerbated inflammatory arthritis in response to hyperactive gp130 signalling is independent of IL-17A. Annals of the Rheumatic Diseases 72 (10), pp.1738-1742. (10.1136/annrheumdis-2013-203771)
- Moideen, A. N. et al. 2013. Characterization of enzymes involved in nicotinamide adenine dinucleotide biosynthesis in rheumatoid arthritis synovium and cytokine-stimulated synovial fibroblasts [Abstracts]. Rhuematology 52 (s1), pp.138-139.
- Bonnet, C. et al. 2012. Intra-articular AMPA/kainate glutamate receptor antagonists alleviate inflammation, pain and pathology in rat antigen induced arthritis [Abstract]. Osteoporosis International 23 , pp.S527-S527.
- Greenhill, C. et al. 2012. The regulation of arthritic bone erosions by il-10 [Abstract]. Rhuematology 51 , pp.48-48. (10.1093/rheumatology/kes117)
- Greenhill, C. J. et al. 2012. Cross-talk between IL-10 and the inflammasome regulates bone erosions during rheumatoid arthritis [Abstract]. Immunology 137 , pp.43-44.
- Jones, G. W. et al. 2012. Interleukin-27 receptor-deficient mice develop exacerbated inflammatory arthritis associated with heightened T- and B-cell responses [Abstract]. Rhuematology 51 (s3), pp.43-44. (10.1093/rheumatology/kes117)
- Moideen, A. N. et al. 2012. Nicotinamide adenine dinucleotide (NAD plus) biosynthesis enzymes in rheumatoid arthritis [Abstract]. Rhuematology 51 (s3), pp.142-142. (10.1093/rheumatology/kes108)
- Nowell, M. A. , Evans, L. C. and Williams, A. S. 2012. PBEF/NAMPT/visfatin: a promising drug target for treating rheumatoid arthritis?. Future Medicinal Chemistry 4 (6), pp.751-769. (10.4155/fmc.12.34)
- Bonnet, C. S. et al., 2011. Intra-articular AMPA/kainate glutamate receptor antagonists alleviate inflammation, pain and pathology in rat antigen induced arthritis [Abstract]. International Journal of Experimental Pathology 92 (6), pp.A14-A14. (10.1111/j.1365-2613.2011.00780.x)
- Evans, L. C. et al. 2011. Suppression of leukocyte infiltration and cartilage degradation by selective inhibition of pre-B cell colony-enhancing factor/visfatin/nicotinamide phosphoribosyltransferase: Apo866-mediated therapy in human fibroblasts and murine collagen-induced arthritis. Arthritis and Rheumatism 63 (7), pp.1866-1877. (10.1002/art.30338)
- Greenhill, C. J. et al. 2011. The regulation of arthritic bone erosions by IL-10 [Abstract]. Immunology 135 (s1), pp.158-158. (10.1111/j.1365-2567.2011.03534.x)
- Jones, G. W. et al. 2011. Interleukin-27 receptor-deficient mice develop exacerbated inflammatory arthritis associated with heightened T- and B-cell responses [Abstract]. Immunology 135 (S1), pp.158. (10.1111/j.1365-2567.2011.03534.x)
- Jones, G. W. et al. 2011. Interleukin-27 receptor-deficient mice develop exacerbated inflammatory arthritis associated with heightened T- and B- cell responses [Abstract]. Arthritis and Rheumatism 63 (s10), pp.S978-S978. (10.1002/art.33310)
- Leggate, M. et al., 2010. The response of interleukin-6 and soluble interleukin-6 receptor isoforms following intermittent high intensity and continuous moderate intensity cycling. Cell Stress and Chaperones 15 (6), pp.827-833. (10.1007/s12192-010-0192-z)
- Nowell, M. A. et al. 2009. Therapeutic targeting of IL-6 trans signaling counteracts STAT3 control of experimental inflammatory arthritis. Journal of Immunology 182 (1), pp.613-622.
- Longhi, M. P. et al., 2008. Interleukin-6 is crucial for recall of influenza-specific memory cd4+ t cells. PLoS Pathogens 4 (2) e1000006. (10.1371/journal.ppat.1000006)
- Jones, S. A. et al. 2008. Appreciating the balance between classical interleukin (IL)-6 receptor signaling and IL-6 trans-signaling: implications for arthritis progression. Immunology Endocrine & Metabolic Agents in Medicinal Chemistry 8 (3), pp.235-246.
- Caterson, B. et al. 2008. Chondroitin sulphate motifs as biomarkers for the stem/progenitor cell niche in musculoskeletal tissues. European Cells and Materials 16 (Supp 2), pp.47-47.
- Hayes, A. J. et al. 2008. Chondroitin sulfate sulfation motifs as putative biomarkers for isolation of articular cartilage progenitor cells. Journal of Histochemistry & Cytochemistry 56 (2), pp.125-38. (10.1369/jhc.7A7320.2007)
- Jones, G. W. et al. 2008. TL1A negatively regulates development of T helper 17 cells [Abstract]. Rheumatology 47 (S2), pp.II20-II20. (10.1093/rheumatology/kem509)
- Nowell, M. A. and Williams, A. S. 2008. Selective inhibition of PBEF activity with a small molecule inhibitor, APO866 ameliorates collagen-induced arthritis [Abstract]. Rheumatology 47 , pp.II58-II59.
- Williams, A. S. et al. 2007. Interferon-γ protects against the development of structural damage in experimental arthritis by regulating polymorphonuclear neutrophil influx into diseased joints. Arthritis & Rheumatism 56 (7), pp.2244-2254. (10.1002/art.22732)
- Campinho, M. A. et al., 2007. Troponin T isoform expression is modulated during Atlantic Halibut metamorphosis. BMC Developmental Biology 7 (1) 71. (10.1186/1471-213X-7-71)
- Carty, S. M. et al. 2007. Combination therapy with etanercept and sgp130 for rheumatoid arthritis is more effective than monotherapy [Abstract]. Rheumatology 46 (s1), pp.I18-I18. (10.1093/rheumatology/kem1007)
- Dimitrov, S. et al., 2006. Sleep enhances IL-6 trans-signaling in humans. The FASEB Journal 20 (12), pp.2174-2176. (10.1096/fj.06-5754fje)
- Nowell, M. A. et al. 2006. Regulation of pre-B cell colony-enhancing factor by STAT-3-dependent interleukin-6 trans-signaling: implications in the pathogenesis of rheumatoid arthritis. Arthritis & Rheumatism 54 (7), pp.2084-2095. (10.1002/art.21942)
- Peake, N. J. et al., 2006. Interleukin-6 signalling in juvenile idiopathic arthritis is limited by proteolytically cleaved soluble interleukin-6 receptor. Rheumatology 45 (12), pp.1485-1489. (10.1093/rheumatology/kel154)
- Richards, P. J. et al., 2006. Functional characterization of a soluble gp130 isoform and its therapeutic capacity in an experimental model of inflammatory arthritis. Arthritis & Rheumatism 54 (5), pp.1662-1672. (10.1002/art.21818)
- Carty, S. M. et al. 2006. TINFa and IL-6/slL-6R interactions regulate the magnitude and the phenotype of synovial Leucocyte infiltration in rheumatoid arthritis [Abstract]. Arthritis and Rheumatism 54 (9), pp.S597-S597.
- Carty, S. M. et al., 2005. Interleukin 6 (IL-6) signalling in rheumatoid arthritis. Rheumatology 44 , pp.I38-I38.
- McLoughlin, R. M. et al. 2004. Differential regulation of neutrophil-activating chemokines by IL-6 and its soluble receptor isoforms. The Journal of Immunology 172 , pp.5676-83.
- Nowell, M. A. et al. 2003. Soluble IL-6 receptor governs IL-6 activity in experimental arthritis: blockade of arthritis severity by soluble glycoprotein 130. The Journal of Immunology 171 (6), pp.3202-3209.
- Coffey, M. J. et al. 2001. Catalytic consumption of nitric oxide by 12/15- lipoxygenase: inhibition of monocyte soluble guanylate cyclase activation. Proceedings of the National Academy of Sciences of the United States of America (PNAS) ISSN 1091-6490 98 (14), pp.8006-8011. (10.1073/pnas.141136098)
- Power, D. M. et al., 2001. Thyroid hormones in growth and development of fish. Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology 130 (4), pp.447-459. (10.1016/S1532-0456(01)00271-X)
- Nowell, M. A. et al. 2000. Cloning and expression of an elongation factor-1a in sea bream (Sparus aurata) larvae and adult tissue. Marine Biotechnology 2 (2), pp.173-179. (10.1007/s101269900022)
Bywgraffiad
Rheolwr Datblygu Ymchwil (Y Gwasanaeth Ymchwil) – Coleg ABCh yn wynebu
Cardiff University / Prifysgol Caerdydd
Medi 2022 - Presennol
- Rheolwr Datblygu Ymchwil Coleg y Gwyddorau Ffisegol a Pheirianneg ym Mhrifysgol Caerdydd. Gweithio mewn Gwasanaethau Ymchwil ac Arloesi
Medrau: Strategaeth Ymchwil, Datblygu Ymchwil, Cyngor cyllido, Cymorth Grant a Chyngor Grant, Rheolaeth
Dirprwy Reolwr Busnes (Interim)
Cardiff University / Prifysgol Caerdydd
Ionawr 2021 - Hydref 2022
- Cefnogi'r Rhag Is-Ganghellor (PVC) Ymchwil, Arloesi a Menter a'u Rheolwr Busnes / Rheolwr REF i gyflawni ar draws cylch gwaith y portffolio ymchwil, trwy gydlynu, cyswllt, cyngor a rheolaeth busnes strategol
Medrau: Strategaeth Ymchwil, Ysgrifennu Achos Busnes, Cydweithredu, Adeiladu Rhwydwaith , Sgiliau rhyngbersonol, Rheoli
Swyddog Datblygu Ymchwil (Gwasanaethau Ymchwil ac Arloesi) – Coleg BLS yn wynebu
Cardiff University / Prifysgol Caerdydd
Gorff 2014 - Hydref 2022
- Gweithio ar draws Prifysgol Caerdydd i ddatblygu ymchwil a rheoli prosiectau prosiectau strategol y Brifysgol.
Sgiliau: Datblygu Ymchwil, Cyngor cyllido, Cymorth Grant, cyngor a hyfforddiant Cymrodoriaeth, Cydweithredu, Creu rhwydweithiau, Rheoli
Dadansoddwr Ymchwil Ser Cymru - Swyddfa Prif Gynghorydd Gwyddonol Cymru
Llywodraeth Cymru / Welsh Government
Ebrill 2013 - Mai 2014
- Mae cyngor ac arbenigedd gwyddonol i adran Wyddoniaeth Llywodraeth Cymru ynghylch prosiectau yn gysylltiedig â Rhaglen Ymchwil Sêr Cymru.
- Briffiau, adroddiadau a diweddariadau ysgrifenedig, ymgysylltu â phartïon â diddordeb e.e. Cyngor Cyllido Addysg Uwch Cymru (CCAUC) a Sefydliadau Addysg Uwch (SAUau)
- Hyfforddiant yn Prince2®
Sgiliau: Rheoli Prosiectau, Dadansoddi Data
Arthritis Research UK Cymrawd Datblygu Gyrfa Anghlinigol - School of Medicine
Cardiff University / Prifysgol Caerdydd
Ionawr 2007 - Mawrth 2012
- Ennill Cymrodoriaeth Datblygu Gyrfa (Arthritis Research UK)
- Cynnal ymchwil i ddeall yn well y dull gweithredu o brotein newydd NAMPT (NicotinAMide Phosphoribosyl Transferase), mewn arthritis, gyda'r bwriad o reoli ei weithgareddau
- Prosiectau ymchwil a reolir yn llwyddiannus o lefel israddedig i PhD
- Modiwl a addysgir ar gyfer myfyrwyr BSc rhyng-gyfrifedig
- Cyhoeddedig erthyglau ymchwil gwreiddiol, erthyglau adolygu a chrynodebau cyfarfodydd rhyngwladol.
- Dyfernir >£450k mewn cyllid grant allanol
- Arweinydd academaidd ar gyfer dau gyfleuster biotechnoleg.
Sgiliau: Rheoli prosiectau / ymchwil, goruchwyliaeth PGR, Ymchwil, biocemeg, Bioleg Foleciwlaidd, Bioddelweddu, dadansoddi data, addysgu Prifysgol
Contact Details
[email protected]
+44 29208 79032
sbarc|spark, Ystafell 03.14, Heol Maendy, Cathays, Caerdydd, CF24 4HQ
+44 29208 79032
sbarc|spark, Ystafell 03.14, Heol Maendy, Cathays, Caerdydd, CF24 4HQ